对于胃腺癌的胃切除术后的长期生存而言,使用他类药物:瑞典基于人口的队列研究
Dag Holmberg1, Joonas H Kauppila2,3, Johannes Asplund2
1Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Retzius Street 13A, 4th Floor, 171 77, Stockholm, Sweden. dag.holmberg@ki.se.
概括
这项研究发现,在胃癌手术前使用他类药物并没有改善患者的生存率. 研究表明,在服用他类药物的患者中,疾病特异性或全因死亡率没有显著差异.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 以前的研究表明,他类药物可以改善胃癌的生存率,但由于方法上的限制,缺乏确的证据.
- 胃腺癌是全球癌症死亡的重要原因之一.
研究的目的:
- 研究治疗性胃切除术的胃腺癌患者的他类药物使用和生存结果之间的关联.
- 为这种患者群体提供关于他类药物的有效性改善生存率的有效证据.
主要方法:
- 在瑞典进行的一项全国性基于人口的队列研究 (2006-2015年) 包括因胃腺癌而接受胃切除术的患者.
- 在手术前一年使用他类药物与不使用他类药物进行了比较,并使用5年疾病特异性和全因死亡率来评估结果.
- 使用多变量考克斯回归分析,调整了许多临床和人口因素.
主要成果:
- 静止剂使用 (26.3%的患者) 与5年疾病特异性死亡率 (HR 0.99) 或全因死亡率 (HR 0.94) 的统计学显著降低无关.
- 在各种子组中没有观察到生存益处,包括年龄,性别,阿司匹林使用,瘤阶段或他类药物使用时间.
结论:
- 在瑞典,经过胃腺癌治疗性胃切除术的患者中,术后使用他类药物似乎不会提高5年生存率.
- 这些发现表明,在这种特定的临床背景下,他类药物可能对改善存活率没有好处.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
265
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
700
相关概念视频
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:20Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
303
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
303